dr. A.M.E. (Annemiek) Walenkamp

Medical Oncologist (MD)


  1. Data-driven Prioritization And Evaluation Of Novel Therapeutic Targets In Glioblastoma

    Brahm, C. G., Walenkamp, A. M. E., van Linde, M. E., Abdul, U. K., Westerman, B. A., Verheul, H. M. W. & Fehrmann, R. S. N., Sep-2018, In : Neuro-Oncology. 20, Suppl_3, p. 283 1 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  2. Web-based personalised information and support for patients with a neuroendocrine tumour: randomised controlled trial

    de Hosson, L. D., Bouma, G., Stelwagen, J., van Essen, H., de Bock, G. H., de Groot, D. J. A., de Vries, E. G. E. & Walenkamp, A. M. E., 28-Feb-2019, In : Orphanet journal of rare diseases. 14, 8 p., 60.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Oncologie

    de Vries, E. G. E., Reyners, A. K. L., Schroder, C., Walenkamp, A. & Gietema, J. A., 2010, Interne Geneeskunde. Stehouwer, CDA., Koopmans, RP. & van der Meer, J. (eds.). Bohn, Stafleu, Van Loghum

    Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

  4. Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naive Advanced Pancreatic Neuroendocrine Tumors

    Salazar, R., Garcia-Carbonero, R., Libutti, S. K., Hendifar, A. E., Custodio, A., Guimbaud, R., Lombard-Bohas, C., Ricci, S., Klumpen, H-J., Capdevila, J., Reed, N., Walenkamp, A., Grande, E., Safina, S., Meyer, T., Kong, O., Salomon, H., Tavorath, R. & Yao, J. C., Jul-2018, In : The Oncologist. 23, 7, p. 766-e90 6 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (82) »

View graph of relations

ID: 393545